Zhang, Dong <br/><br/>
β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.  [electronic resource] 

 -  Cancer biology & therapy  Jul 2010 
 - 19-29 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.4161/cbt.10.1.11944  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-2 Receptor Antagonists--pharmacology<br/>Animals<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Cyclic AMP Response Element-Binding Protein--antagonists & inhibitors<br/>Cyclooxygenase 2--genetics<br/>Electrophoretic Mobility Shift Assay<br/>Enzyme-Linked Immunosorbent Assay<br/>Humans<br/>Matrix Metalloproteinase 2--genetics<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>NF-kappa B--antagonists & inhibitors<br/>Neoplasm Invasiveness<br/>Pancreatic Neoplasms--drug therapy<br/>Propanolamines--pharmacology<br/>RNA, Messenger--genetics<br/>Receptors, Adrenergic, beta--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transcription Factor AP-1--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor A--genetics